Long-term survival after resection of pancreatic cancer: A single-center retrospective analysis

World Journal of Gastroenterology

Volumn 21, Issue 1, 2015, Pages 262-268

  Yamamoto, Takehito ^a   Yagi, Shintaro ^a   Kinoshita, Hiromitsu ^a   Sakamoto, Yusuke ^a   Okada, Kazuyuki ^a   Uryuhara, Kenji ^a   Morimoto, Takeshi ^a   Kaihara, Satoshi ^a   Hosotani, Ryo ^a  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

Author keywords

Long term survival; Long term survivor; Pancreatic cancer; Prognostic factor; R0 resection

Indexed keywords

AGED; ARTICLE; CANCER PROGNOSIS; CONTROLLED STUDY; FEMALE; HUMAN; LONG TERM SURVIVAL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PANCREAS SURGERY; POSTOPERATIVE PERIOD; SURVIVAL RATE; SURVIVAL TIME; TUMOR INVASION; TUMOR VOLUME; ADJUVANT CHEMOTHERAPY; ADVERSE EFFECTS; BLOOD; CANCER STAGING; CHI SQUARE DISTRIBUTION; DISEASE FREE SURVIVAL; JAPAN; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MORTALITY; MULTIVARIATE ANALYSIS; PANCREAS RESECTION; PANCREATIC NEOPLASMS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; TIME; TREATMENT OUTCOME;

CA 19-9 ANTIGEN; DU-PAN-2 ANTIGEN, HUMAN; TUMOR ANTIGEN;

AGED; ANTIGENS, NEOPLASM; CA-19-9 ANTIGEN; CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; JAPAN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84920915121     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i1.262     Document Type: Article

References (25)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60: 277-300 [PMID: 20610543 DOI: 10.3322/caac.20073]
2. Reber HA, Gloor B. Radical pancreatectomy. Surg Oncol Clin N Am 1998; 7: 157-163 [PMID: 9443993]
3. Begg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA 1998; 280: 1747-1751 [PMID: 9842949 DOI: 10.1001/jama.280.20.1747]
4. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe KD. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 2000; 4: 567-579 [PMID: 11307091]
5. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 2003; 237: 74-85 [PMID: 12496533 DOI: 10.1097/01.SLA.0000041266.10047.38]
6. Lee SR, Kim HO, Son BH, Yoo CH, Shin JH. Prognostic factors associated with long-term survival and recurrence in pancreatic adenocarcinoma. Hepatogastroenterology 2013; 60: 358-362 [PMID: 23574658 DOI: 10.5754/hge12727]
7. Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg 2009; 13: 1337-1344 [PMID: 19418101 DOI: 10.1007/s11605-009-0919-2]
8. Wentz SC, Zhao ZG, Shyr Y, Shi CJ, Merchant NB, Washington K, Xia F, Chakravarthy AB. Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma. World J Gastrointest Oncol 2012; 4: 207-215 [PMID: 23444312 DOI: 10.4251/wjgo.v4.i10.207]
9. Chatterjee D, Katz MH, Rashid A, Wang H, Iuga AC, Varadhachary GR, Wolff RA, Lee JE, Pisters PW, Crane CH, Gomez HF, Abbruzzese JL, Fleming JB, Wang H. Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma. Am J Surg Pathol 2012; 36: 409-417 [PMID: 22301497 DOI: 10.1097/PAS.0b013e31824104c5]
10. Richter A, Niedergethmann M, Sturm JW, Lorenz D, Post S, Trede M. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 2003; 27: 324-329 [PMID: 12607060 DOI: 10.1007/s00268-002-6659-z]
11. Imamura M, Doi R, Imaizumi T, Funakoshi A, Wakasugi H, Sunamura M, Ogata Y, Hishinuma S, Asano T, Aikou T, Hosotani R, Maetani S. A randomized multicenter trial comparing resection and radiochemotherapy for resectable locally invasive pancreatic cancer. Surgery 2004; 136: 1003-1011 [PMID: 15523393]
12. Japan Pancreas Society. Classification of pancreatic carcinoma. sixth ed. Tokyo: Kanehara, 2009
13. International Union Against Cancer. TNM classification of malignant tumors. sixth ed. New York: Weily-Liss, 2002
14. Nagakawa T, Sanada H, Inagaki M, Sugama J, Ueno K, Konishi I, Ohta T, Kayahara M, Kitagawa H. Long-term survivors after resection of carcinoma of the head of the pancreas: significance of histologically curative resection. J Hepatobiliary Pancreat Surg 2004; 11: 402-408 [PMID: 15619016 DOI: 10.1007/s00534-004-0917-4]
15. Jamieson NB, Chan NI, Foulis AK, Dickson EJ, McKay CJ, Carter CR. The prognostic influence of resection margin clearance following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Gastrointest Surg 2013; 17: 511-521 [PMID: 23297028 DOI: 10.1007/s11605-012-2131-z]
16. Nitecki SS, Sarr MG, Colby TV, van Heerden JA. Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995; 221: 59-66 [PMID: 7826162 DOI: 10.1097/00000658-199501000-00007]
17. Manabe T, Ohshio G, Baba N, Miyashita T, Asano N, Tamura K, Yamaki K, Nonaka A, Tobe T. Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas. Cancer 1989; 64: 1132-1137 [PMID: 2547508]
18. Yeo CJ, Cameron JL, Sohn TA, Coleman J, Sauter PK, Hruban RH, Pitt HA, Lillemoe KD. Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome. Ann Surg 1999; 229: 613-622; discussion 622-624 [PMID: 10235519 DOI: 10.1097/00000658-199905000-00003]
19. Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, Pasquali C, Klöppel G, Dhaene K, Michelassi F. Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. Ann Surg 1998; 228: 508-517 [PMID: 9790340 DOI: 10.1097/00000658-199810000-00007]
20. Reddy SK, Tyler DS, Pappas TN, Clary BM. Extended resection for pancreatic adenocarcinoma. Oncologist 2007; 12: 654-663 [PMID: 17602057]
21. Michalski CW, Kleeff J, Wente MN, Diener MK, Büchler MW, Friess H. Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer. Br J Surg 2007; 94: 265-273 [PMID: 17318801 DOI: 10.1002/bjs.5716]
22. Farnell MB, Aranha GV, Nimura Y, Michelassi F. The role of extended lymphadenectomy for adenocarcinoma of the head of the pancreas: strength of the evidence. J Gastrointest Surg 2008; 12: 651-656 [PMID: 18085343 DOI: 10.1007/s11605-007-0451-1]
23. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, Gutberlet K, Kettner E, Schmalenberg H, Weigang-Koehler K, Bechstein WO, Niedergethmann M, Schmidt-Wolf I, Roll L, Doerken B, Riess H. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA 2007; 297: 267-277 [PMID: 17227978]
24. Ueno H, Kosuge T, Matsuyama Y, Yamamoto J, Nakao A, Egawa S, Doi R, Monden M, Hatori T, Tanaka M, Shimada M, Kanemitsu K. A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer 2009; 101: 908-915 [PMID: 19690548]
25. Murakami Y, Uemura K, Sudo T, Hashimoto Y, Kondo N, Nakagawa N, Sasaki H, Sueda T. Early initiation of adjuvant chemotherapy improves survival of patients with pancreatic carcinoma after surgical resection. Cancer Chemother Pharmacol 2013; 71: 419-429 [PMID: 23178955 DOI: 10.1007/ s00280-012-2029-1]